ELN and triple-A syndrome: Based on this, an elastin antibody tethered to nanoparticles to target aneurysms has been designed.[110] The drugs specifically target AAA and accumulate in the degraded elastic layer in the mouse model after treatment with the system.[111] Thus, it would be possible to use engineered EVs to treat AAA.